Patent · US Active

Oral soft gel capsule containing psychedelic compound

US11766445B2 · kind B2 · utility

0Cited by

1References

26Claims

0Family size

Inventors

Tony LaRosa · Calabasas, US
Robert Davidson · Calabasas, US
David Reid · Oxnard, US

Key dates

Filing date	Jul 14, 2020
Grant date	Sep 26, 2023
Priority date	—
Expiry date	Aug 28, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/44
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided is an oral soft gel capsule that includes a psychedelic compound. Also provided is a method of treating in a subject a disease or disorder ameliorated by a psychedelic compound, that includes orally administering to a subject an oral soft gel capsule that includes a therapeutically effective amount of the psychedelic compound. Also provided is a method of orally administering to a subject an oral soft gel capsule that includes a therapeutically effective amount of the psychedelic compound. Also provided is a method of orally administering to a subject an oral soft gel capsule that includes a low dose (e.g., microdose or sub-therapeutic dose) of the psychedelic compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.